Treatment
Medication clinical trials
We’re tracking 7,140 recruiting studies that include Medication, each written for real people, not researchers, below.
Recruiting studies
- NCT07373275Enrolling by invitation
Lifestyle Medicine for Teen Migraine
This study tests whether a lifestyle medicine program (like healthy habits and stress management) can help reduce migraine headaches in teenagers. It's for teens who get frequent migraines and are patients at certain MaineHealth clinics.
Scarborough, MaineAges 14–18 - NCT07376577Recruiting
Sedation for older adults having ERCP
This trial tests a combination of two sedatives (anricofen and ciprofol) for deep sedation in older adults having an ERCP procedure. It aims to see if this combination is safe and effective for patients between 60 and 90 years old with mild to moderate health conditions.
Xinxiang, HenanAges 60–90 - NCT07372586Recruiting
Behavioral health support after ICU stay
This study tests a collaborative care model for mental health and recovery after an ICU stay. You might qualify if you visit the MUSC ICU Recovery Clinic within six months of leaving the hospital.
Charleston, South CarolinaAges 18 years+ - NCT07372729Recruiting
Smartwatch program for heart health in overweight adults
This trial tests if a smartwatch app can help people who are overweight and have slightly high blood pressure, sugar, or cholesterol improve their heart health. If you qualify, you'll use a smartwatch to track your activity and get coaching.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07374419RecruitingPhase 1/Phase 2
Atamparib for advanced lung cancer with KRAS mutation
This trial tests a drug called Atamparib for people with advanced lung cancer that has a specific genetic change called a KRAS mutation. It is for patients whose cancer has continued to grow after at least one standard treatment.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT04457154Recruiting
Registry for teens and young adults with OSA who can’t use CPAP
This study collects information in a registry to help doctors understand outcomes for young people with moderate-to-severe obstructive sleep apnea who cannot use CPAP and may use an implantable breathing stimulation device. You might qualify if you’ve tried and couldn’t tolerate CPAP and you’re able/willing to get and use the device and return for follow-ups and sleep tests.
Aurora, ColoradoAges 18–21 - NCT03720197Recruiting
Registry for people living with type 1 diabetes
This is a registry that collects information from people living with type 1 diabetes. It may help researchers better understand the condition and improve future care.
Edmonton, AlbertaAges Any age - NCT05908331Recruiting
Balloon treatment test for narrowed stents in heart arteries
This trial tests whether a special drug-coated balloon (“MagicTouch”) can treat re-narrowing inside a previously placed stent. It may help patients whose stent has become blocked again, by improving blood flow and reducing repeat narrowing.
Birmingham, AlabamaAges 18–110 - NCT06448520Recruiting
Muscle power sprint test in children
This study is measuring how fast and powerful kids' legs are during a short sprint test. Researchers want to collect normal values from healthy children so doctors can compare results in the future.
Rotterdam, South HollandAges 5–12 - NCT06453343Recruiting
Comparing two surgical approaches for cochlear implants
This study compares two different surgical methods for placing a cochlear implant (a device that helps with hearing). It is for adults who have lost hearing after learning to speak and are eligible for a specific type of implant. The goal is to see which approach works best.
NijmegenAges 18 years+ - NCT07366879Recruiting
Exercise program for newly diagnosed pulmonary hypertension
This study tests whether a home-based exercise program, added to your regular medications, can help people who are newly diagnosed with pulmonary arterial hypertension feel better and improve their daily function.
GlasgowAges 18 years+ - NCT07362992RecruitingEarly Phase 1
Tranexamic acid gel to reduce bleeding during cesarean
This study tests whether applying a medicine called tranexamic acid directly to the uterus during a scheduled cesarean can reduce bleeding. It may help women who are having their first or second cesarean delivery.
Holon, Central DistrictAges 18–51 - NCT06844942Recruiting
Improving heart artery imaging for chest pain diagnosis
This trial uses a special camera called OCT to take detailed pictures of the heart's arteries. It aims to see if these pictures help doctors better understand blockages and decide on treatment for stable chest pain.
Warsaw, Mazowieckie VoivodenshipAges 18 years+ - NCT07363603RecruitingPhase 1/Phase 2
Tianasen for GNAO1-related epilepsy and movement disorders
This trial tests a new drug called Tianasen for children with a specific GNAO1 gene change who have seizures and movement problems that haven't improved with standard treatments. The drug is given via a lumbar puncture (spinal tap) and aims to reduce symptoms.
MoscowAges 1–14 - NCT07366099Recruiting
Special PET scan for tumor-induced osteomalacia
This trial tests a new PET/CT scan (using a tracer called Al18F-NOTA-LM3) to better find tumors causing TIO, a condition that leads to bone softening and weakness. It may help doctors diagnose and treat TIO more accurately.
Beijing, Beijing MunicipalityAges 18–80 - NCT07364903Recruiting
Family care for preterm babies in the hospital
This trial tests whether a program that brings parents into the daily care of their preterm or low-birth-weight baby can help the baby recover faster and go home sooner. If you can spend up to 8 hours a day at the hospital, this study may be a good fit.
Mek'ele, TigrayAges Any age - NCT07369648Recruiting
Magnetic brain stimulation plus rehab for stroke recovery
This trial tests if a treatment that uses magnetic pulses on the head (called repetitive transcranial magnetic stimulation) combined with physical therapy can help improve movement and daily activities after a stroke. It is for people who had their first ischemic stroke and have weakness on one side.
HanoiAges 18–80 - NCT07363551Recruiting
Omega-3 for depression in young people
This trial tests if omega-3 fatty acid supplements can improve depression in young people by reducing inflammation and changing gut bacteria. You may be eligible if you are a young person with a current major depressive episode.
Taichung, TaichungAges 13–18 - NCT07363382RecruitingPhase 1/Phase 2
Testing GRPR PET Scan for Prostate Cancer
This study tests a new imaging method (GRPR PET) to help better see and stage prostate cancer. If you have prostate cancer, this scan may give doctors more detail about where the cancer is located.
Fuzhou, FujianAges 18–90 - NCT07369557Recruiting
Mindfulness training with TMS for depression
This trial combines mindfulness training with accelerated TMS therapy for depression. It tests if adding mindfulness helps improve treatment outcomes.
Charleston, South CarolinaAges 18–80 - NCT07370623Recruiting
AI system to help assess breathing trouble in children
This study is testing an artificial intelligence system that helps doctors evaluate breathing problems in children. It uses a camera and clinical data to see if the AI can make accurate assessments in the emergency room.
Seongnam-si, Gyeonggi-doAges birth–12 years - NCT07368946Recruiting
Phosphate study for people with kidney disease
This study looks at how the body handles phosphate in people with chronic kidney disease. It may help researchers understand how to better manage phosphate levels to improve health.
Dallas, TexasAges 18 years+ - NCT07366684Recruiting
Heart attack study for adults 75 and older
This study looks at how frailty and other health factors affect recovery in people 75 and older who have had a heart attack or unstable chest pain. It may help doctors better understand who is at higher risk and how to improve care for older adults.
NišAges 75 years+ - NCT07365306RecruitingPhase 2
Epcoritamab with chemo before stem cell transplant for DLBCL
This trial tests a combination of drugs — epcoritamab, rituximab, gemcitabine, and oxaliplatin — as a ‘salvage’ therapy for people with diffuse large B-cell lymphoma that has come back or not responded to initial treatment. The goal is to shrink the lymphoma enough so you can go on to a stem cell transplant using your own cells.
Duarte, CaliforniaAges 18 years+
Common questions
- Are there clinical trials studying Medication?
- Yes. Clin2 currently lists 7,140 recruiting studies that include Medication, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Medication trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Medication an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Medication or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.